Literature DB >> 25766107

Sirtuins in vascular diseases: Emerging roles and therapeutic potential.

Nunzia D'Onofrio1, Milena Vitiello1, Rosario Casale1, Luigi Servillo1, Alfonso Giovane1, Maria Luisa Balestrieri2.   

Abstract

Silent information regulator-2 (Sir-2) proteins, or sirtuins, are a highly conserved protein family of histone deacetylases that promote longevity by mediating many of the beneficial effects of calorie restriction which extends life span and reduces the incidence of cancer, cardiovascular disease (CVD), and diabetes. Here, we review the role of sirtuins (SIRT1-7) in vascular homeostasis and diseases by providing an update on the latest knowledge about their roles in endothelial damage and vascular repair mechanisms. Among all sirtuins, in the light of the numerous functions reported on SIRT1 in the vascular system, herein we discuss its roles not only in the control of endothelial cells (EC) functionality but also in other cell types beyond EC, including endothelial progenitor cells (EPC), smooth muscle cells (SMC), and immune cells. Furthermore, we also provide an update on the growing field of compounds under clinical evaluation for the modulation of SIRT1 which, at the state of the art, represents the most promising target for the development of novel drugs against CVD, especially when concomitant with type 2 diabetes.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  Cardiovascular disease; Endothelial progenitor cell; Endothelium; Sirtuins; Vascular dysfunction

Mesh:

Substances:

Year:  2015        PMID: 25766107     DOI: 10.1016/j.bbadis.2015.03.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  40 in total

Review 1.  Metabolic Regulation of Angiogenesis in Diabetes and Aging.

Authors:  Naoki Sawada; Zolt Arany
Journal:  Physiology (Bethesda)       Date:  2017-07

Review 2.  Sirtuins, aging, and cardiovascular risks.

Authors:  Gaia Favero; Lorenzo Franceschetti; Luigi Fabrizio Rodella; Rita Rezzani
Journal:  Age (Dordr)       Date:  2015-06-23

3.  Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics.

Authors:  Suowen Xu; Danielle Kamato; Peter J Little; Shinichi Nakagawa; Jaroslav Pelisek; Zheng Gen Jin
Journal:  Pharmacol Ther       Date:  2018-11-13       Impact factor: 12.310

Review 4.  SIRT1 and SIRT6 Signaling Pathways in Cardiovascular Disease Protection.

Authors:  Nunzia D'Onofrio; Luigi Servillo; Maria Luisa Balestrieri
Journal:  Antioxid Redox Signal       Date:  2017-06-29       Impact factor: 8.401

5.  Metformin treatment status and abdominal aortic aneurysm disease progression.

Authors:  Naoki Fujimura; Jiang Xiong; Ellen B Kettler; Haojun Xuan; Keith J Glover; Matthew W Mell; Baohui Xu; Ronald L Dalman
Journal:  J Vasc Surg       Date:  2016-04-19       Impact factor: 4.268

Review 6.  Harnessing the Power of SIRT1 and Non-coding RNAs in Vascular Disease.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2017       Impact factor: 1.990

7.  The role of SIRT6 in tumors.

Authors:  Vanessa Desantis; Aurelia Lamanuzzi; Angelo Vacca
Journal:  Haematologica       Date:  2018-01       Impact factor: 9.941

8.  Histone deacetylation contributes to low extracellular superoxide dismutase expression in human idiopathic pulmonary arterial hypertension.

Authors:  Eva Nozik-Grayck; Crystal Woods; Robert S Stearman; Sujatha Venkataraman; Bradley S Ferguson; Kalin Swain; Russell P Bowler; Mark W Geraci; Kaori Ihida-Stansbury; Kurt R Stenmark; Timothy A McKinsey; Frederick E Domann
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-05-27       Impact factor: 5.464

Review 9.  Moving to the Rhythm with Clock (Circadian) Genes, Autophagy, mTOR, and SIRT1 in Degenerative Disease and Cancer.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2017       Impact factor: 1.990

Review 10.  FoxO Transcription Factors and Regenerative Pathways in Diabetes Mellitus.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2015       Impact factor: 1.990

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.